The publication detail shows the title, authors (with indicators showing other profiled authors), information on the publishing organization, abstract and a link to the article in PubMed. This abstract is what is used to create the fingerprint of the publication. If any grants are referenced by the publication, they will be listed here as well.
Biology of CD34+CD38- cells in lymphohematopoiesis.
E M Novelli; M Ramirez; C I Civin (Profiled Author: Curt Civin)
Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA. novelenm @ welchlink.welch.jhu.edu
Leukemia & lymphoma 1998;31(3-4):285-93.
Since the discovery of the CD34 stem/progenitor cell antigen, considerable progress has been made in further purifying human lymphohematopoietic stem cells (HSC). These studies have identified a number of antigens which can be targeted to subfractionate the CD34+ cell population. In particular, several lines of evidence suggest that the rare CD38(-)subpopulation of CD34+ cells may be enriched in HSC. This review briefly summarizes relevant knowledge concerning the CD38 molecule and the results of in vitro and in vivo studies of CD34+38(-)cells. Possible clinical uses for purified CD34+38(-)cells are outlined.
This section shows information related to the publication - computed using the fingerprint of the publication - including related publications, related experts and related grants with fingerprints representing significant amounts of overlap between their fingerprint and this publication. The red dots indicate whether those experts or terms appear within the publication, thereby showing potential and actual connections.
M Ramírez; G A Rottman; L D Shultz; C I CivinExperimental hematology 1998;26(4):332-44.
C I Civin; S D GoreJournal of hematotherapy 1993;2(2):137-44.
C I Civin; G Almeida-Porada; M J Lee; J Olweus; L W Terstappen; E D ZanjaniBlood 1996;88(11):4102-9.
Appears in this Publication
Author of this Publication